Regeneron antibody cocktail works against UK and South African variants, study finds
Regeneron has released research on the company's coronavirus antibody cocktail that found the cocktail retains its potency against the U.K. and South African variants of the virus. The study was done in conjunction with Columbia University researcher Dr. David Ho and has not yet been peer-reviewed. CNBC's Meg Tirrell reports.
UP NEXT
UP NEXT
-
Am I diversified? Cramer's call
CNBC
-
White House juggling response to Microsoft, SolarWinds hacks
CNBC
-
David Tepper says he's getting bullish on stocks for a very specific reason
CNBC
-
BofA's Savita Subramanian on what key market indicators are telling investors
CNBC
-
Oil prices have risen 38% in the past year — Here's what may be next
CNBC
-
Pandemic spending is driving record debt but it may also help avert economic meltdown
CNBC
-
Cue Health CEO on FDA emergency authorization for Covid at-home test
CNBC
-
The rise of NFTs, and why people are collecting moments and assets differently now
CNBC
-
Kilburg: It's interesting the amount of emotion the market
CNBC
-
Covid health-care costs go beyond hospitalization for some patients
CNBC
-
Head of University Hospital Newark on where we stand one year into the COVID pandemic
CNBC
-
What the $1.9 trillion stimulus package could mean for the market
CNBC
-
Top-ranked mid-cap fund manager finds opportunity in foodservice and gaming stocks
CNBC
-
Mackenzie Scott remarries after 2019 divorce from Jeff Bezos
CNBC
-
Markets are in a 'danger zone,' says B. Riley's Mark Grant
CNBC
-
The Senate passed Biden's $1.9 trillion relief bill — Here's what to expect next
CNBC